Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001887982 | SCV002117759 | likely benign | not provided | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004526151 | SCV005040047 | uncertain significance | not specified | 2024-03-07 | criteria provided, single submitter | clinical testing | Variant summary: COL2A1 c.135T>A (p.Asp45Glu) results in a conservative amino acid change located in the VWFC domain (IPR001007) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 249098 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.135T>A in individuals affected with Achondrogenesis, Type II and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1355187). Based on the evidence outlined above, the variant was classified as uncertain significance. |